Mandy Madiredjo
About
In The Last Decade
Mandy Madiredjo
8 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Molecular Biology 2.4k
- Oncology 1.2k
- Cancer Research 533
- Radiology, Nuclear Medicine and Imaging 407
- Pulmonary and Respiratory Medicine 320
Countries citing papers authored by Mandy Madiredjo
This map shows the geographic impact of Mandy Madiredjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy Madiredjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy Madiredjo more than expected).
Fields of papers citing papers by Mandy Madiredjo
This network shows the impact of papers produced by Mandy Madiredjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy Madiredjo. The network helps show where Mandy Madiredjo may publish in the future.
Co-authorship network of co-authors of Mandy Madiredjo
This figure shows the co-authorship network connecting the top 25 collaborators of Mandy Madiredjo. A scholar is included among the top collaborators of Mandy Madiredjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy Madiredjo. Mandy Madiredjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation | Oncotarget | Linda Smit, Katrien Berns et al. | 61 |
| 2 | A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway | PLoS ONE | Jasper Mullenders, Armida W. M. Fabius et al. | 109 |
| 3 | A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer breakdown → | Cancer Cell | Katrien Berns, Hugo M. Horlings et al. | 1236 |
| 4 | The ubiquitin-specific protease USP28 is required for MYC stability | Nature Cell Biology | Nikita Popov, Michael Wanzel et al. | 376 |
| 5 | An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors | Nature Chemical Biology | Thijn R. Brummelkamp, Armida W. M. Fabius et al. | 152 |
| 6 | A large-scale RNAi screen in human cells identifies new components of the p53 pathway breakdown → | Nature Cell Biology | Katrien Berns, E. Marielle Hijmans et al. | 850 |
| 7 | Functional Identification of Cancer-relevant Genes through Large-Scale RNA Interference Screens in Mammalian Cells | Cold Spring Harbor Symposia on Quantitative Biology | Thijn R. Brummelkamp, Katrien Berns et al. | 15 |
| 8 | Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition | Journal of Virology | Atze T. Das, Thijn R. Brummelkamp et al. | 357 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.